Table of ContentsView AllTable of ContentsTypesSymptomsGetting a DiagnosisTreatmentPrognosisResourcesNext in Lymphoma GuideLymphoma Symptoms: What to Look Out For
Table of ContentsView All
View All
Table of Contents
Types
Symptoms
Getting a Diagnosis
Treatment
Prognosis
Resources
Next in Lymphoma Guide
Lymphoma is a type of blood cancer originating from lymphocytes, a type of white blood cell that is part of the immune system. Like all cancers, lymphoma is a serious condition that requires treatment. The most common forms of this disease are Hodgkin and non-Hodgkin lymphoma.
An early symptom of lymphoma is lumps or swelling in the lymph nodes of the neck, armpits, and collarbone. These lumps may be painless, but in some instances, they may cause pain or pressure in the back, chest, and abdomen.
It’s not possible to know you have lymphoma based on symptoms alone. It’s also possible to have lymphoma and not be aware of it until additional symptoms occur.
Types of Lymphoma
Hodgkin Lymphoma
Hodgkin lymphomais most common in males. The age of onset is most likely to occur either in early adulthood (20 to 39) or late adulthood (65 and over). However, people of any age or sex can get this diagnosis. A priorEpstein-Barr virusinfection increases your risk for this condition.
The two main forms of Hodgkin lymphoma are classic and nodular lymphocyte-predominant.
A Note on Gender and Sex TerminologyVerywell Health acknowledges thatsex and genderare related concepts, but they are not the same. To accurately reflect our sources, this article uses terms like “female,” “male,” “woman,” and “man” as the sources use them.
A Note on Gender and Sex Terminology
Verywell Health acknowledges thatsex and genderare related concepts, but they are not the same. To accurately reflect our sources, this article uses terms like “female,” “male,” “woman,” and “man” as the sources use them.
Non-Hodgkin Lymphoma
Non-Hodgkin lymphomabecomes more common as people age. Like Hodgkin lymphoma, a prior Epstein-Barr virus infection increases your risk. So does having an autoimmune condition or taking medications that cause immunosuppression.Males are at greater risk than females.
Non-Hodgkin lymphoma can be indolent (slow-growing) or aggressive. Each type of disease has multiple variations. The type you have and its stage determines potential curability.
Indolent Non-Hodgkin Lymphoma
Follicular lymphomais the most common form of indolent non-Hodgkin lymphoma. This form of the disease may resolve or go into remission without treatment. However, this condition is not considered curable.A recurrence of follicular lymphoma is possible after remission.
People with follicular lymphoma make abnormal B lymphocytes. Scans and a lymph node biopsy are needed to diagnose this condition.
Aggressive Non-Hodgkin Lymphoma
Diffuse large B-cell lymphomais the most common form of aggressive non-Hodgkin lymphoma. Although it is aggressive, diffuse large B-cell lymphoma is considered curable.This form may originate within thelymphatic systemor in any organ of the body.
Diffuse large B-cell lymphoma is further broken down into subtypes. Each subtype produces cells that present differently under a microscope. T-cell/histiocyte-rich B-cell lymphoma, a common subtype, produces large, atypical B cells, which will appear in a scattered formation.
Early Symptoms
Lymphoma symptomsvary based on the type of lymphoma you have. Signs and symptoms of this disease also vary between people.
Swollen lymph nodesare the most common early symptom of lymphoma.These swollen areas feel like lumps. You may notice them in any area of the body, but they are most commonly discovered in the neck, armpits, collarbone, or groin.
Other early signs and symptoms of lymphoma may include:
Progressive Symptoms
As lymphoma progresses, people may experience a group of symptoms referred to as B symptoms. They include:
When to Consider Diagnostic Testing
You can’t self-diagnose lymphoma. You cannot know if you have it based on physical symptoms alone, as the symptoms can be due to many other disease processes. See a healthcare provider if you experience swelling or pain or don’t feel well for weeks.
Your healthcare provider will do a thorough physical exam to look for swollen areas. They will ask about your family history of this and other diseases. They will also ask about your history of infections and current diagnoses you may have.
Testing will be done that either confirm or rule out lymphoma. A lymph node biopsy is the only way to determine if you have lymphoma and, if so, what type. Imaging tests determine if cancer has spread to other parts of the body.These tests are essential for selecting the best kind of treatment.
Causes of Lymphoma TumorsThe underlyingcause of lymphomais not always clear-cut. Male sex and aging are risk factors. So is having a weakened immune system, a family history of this disease, or a personal history of certain viruses and conditions, including Epstein-Barr and HIV.
Causes of Lymphoma Tumors
The underlyingcause of lymphomais not always clear-cut. Male sex and aging are risk factors. So is having a weakened immune system, a family history of this disease, or a personal history of certain viruses and conditions, including Epstein-Barr and HIV.
Lymphoma symptoms can go unnoticed for a long time. In some instances, lymphoma may first be suspected during a routine physical exam. It may also be discovered when you seek medical attention for an unrelated condition or symptoms common to muscle strain, infections, or other conditions.
Getting this diagnosis can come as an unpleasant surprise. If you’re diagnosed with lymphoma, it means you will require treatment, which is based on the type of lymphoma and the stage it’s in.
These tests will be used to confirm the diagnosis and determine the type and stage of lymphoma.
Treatment Options
The type of lymphoma you have, as well as the stage of the cancer, willdetermine the treatmentsthat are recommended. Your overall health and age, as well as your personal preferences for treatment, will also be considered.
Hodgkin Lymphoma Treatment
The goal of Hodgkin lymphoma treatment is to cure it. The most commonly used treatments for this disease are chemotherapy and radiation. Your cancer team may recommend one or both treatments for you.
In instances where chemo and radiation do not produce optimum results, other treatments may be recommended, such as immunotherapy, or high-dose chemotherapy, coupled with a stem cell transplant.
Immunotherapy for Hodgkin lymphoma uses medicines that help the immune system identify and destroy cancer cells.Monoclonal antibodiesare often used. These are highly specific immune system proteins produced in quantity artificially.
Stem cell transplants, also known as bone marrow transplants, replace damaged bone marrow cells with healthy stem cells after high-dose radiation is given.
Non-Hodgkin Lymphoma Treatment
Non-Hodgkin lymphoma treatments vary based on the type and stage of cancer you have.
Chemotherapy is the main treatment used for this disease. It may be used alone or with radiation therapy or immunotherapy drugs.As is the case with Hodgkin lymphoma, high-dose chemo plus stem cell transplants may also be used.
If standard chemotherapy is not helpful, targeted drug therapy may also be tried. This treatment uses medications that interfere with or halt the actions of certain proteins, enzymes, or cancer cells. Velcade (bortezomib) is a proteasome inhibitor sometimes used for non-Hodgkin lymphoma.
Chimeric antigen receptor (CAR) T-cell therapy is used for some types of non-Hodgkin lymphoma.In this type of therapy, the person’s T-cells (a type of immune cell) are harvested and modified in the lab to have receptors that will attach to lymphoma cells. They are induced to multiply and then infused back into the person to attack the lymphoma cells.
If your cancer originated in yourspleenor organs outside of the lymphatic system, surgery may be recommended as a treatment.
Prognosis and Survival Rates
Survival rates are ballpark numbers that reflect upon the experience of people who had cancer at least five years ago. Treatments continue to improve, and clinical trials are typically available for many forms of lymphoma. These innovations yield ever-increasing chances for survival through new and effective treatments and cures.
The stage of your cancer’s progression will impact your potential prognosis. If you have non-Hodgkin lymphoma and cancer has spread to more than one organ outside the lymphatic system, your prognosis may be less optimistic. Age also plays a role. People over 60 may have poorer outcomes with this type of cancer.
The relative five-year survival rates for non-Hodgkin lymphoma are:
Diffuse large B-cell lymphoma:
Follicular lymphoma:
If you have Hodgkin lymphoma, the presence of B symptoms may indicate a less optimistic prognosis. People over 45 may also be more likely to have a less favorable outcome.
The relative five-year survival rates for Hodgkin lymphoma are:
Resources for Patients and Their Families
Many organizations and hospitals offer support groups and other types of care for people with lymphoma.
Summary
Lymphoma is a type of blood cancer that impacts the lymphatic system, immune system, and other parts of the body. The most common types are Hodgkin and non-Hodgkin lymphoma.
Treatment can include chemotherapy, radiation, immunotherapy, and a stem cell transplant, depending on the type and stage of lymphoma. Some types can be cured.
21 SourcesVerywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Blood Cancer UK.Lymphoma.National Cancer Institute.Hodgkin lymphoma treatment (PDQ®) - health professional version.National Cancer Institute.Reed-Sternberg cell.Penn Medicine Abramson Cancer Center.Hodgkin lymphoma.National Cancer Institute.Nodular lymphocyte-predominant Hodgkin lymphoma.Penn Medicine Abramson Cancer Center.Non-Hodgkin lymphoma (non-Hodgkin’s disease).National Cancer Institute.Non-Hodgkin lymphoma treatment (PDQ®) patient version.Follicular Lymphoma Foundation.Blood tests in follicular lymphoma.Lymphoma Research Foundation.Diffuse large B-cell lymphoma.Blood Cancer UK.Lymphoma symptoms and signs.Penn Medicine Cancer Center.Lymphoma diagnosis.Lymphoma Action.Lymphoma and HIV.Penn Medicine Abramson Cancer Center.Lymphoma diagnosis.American Cancer Society.Treating Hodgkin lymphoma.American Cancer Society.Immunotherapy for Hodgkin lymphoma.American Cancer Society.Chemotherapy for non-Hodgkin lymphoma.American Cancer Society.Targeted drug therapy for non-Hodgkin lymphoma.American Cancer Society.Immunotherapy for non-Hodgkin lymphoma.American Cancer Society.Surgery for non-Hodgkin lymphoma.American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.American Cancer Society.Survival rates for Hodgkin lymphoma.
21 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Blood Cancer UK.Lymphoma.National Cancer Institute.Hodgkin lymphoma treatment (PDQ®) - health professional version.National Cancer Institute.Reed-Sternberg cell.Penn Medicine Abramson Cancer Center.Hodgkin lymphoma.National Cancer Institute.Nodular lymphocyte-predominant Hodgkin lymphoma.Penn Medicine Abramson Cancer Center.Non-Hodgkin lymphoma (non-Hodgkin’s disease).National Cancer Institute.Non-Hodgkin lymphoma treatment (PDQ®) patient version.Follicular Lymphoma Foundation.Blood tests in follicular lymphoma.Lymphoma Research Foundation.Diffuse large B-cell lymphoma.Blood Cancer UK.Lymphoma symptoms and signs.Penn Medicine Cancer Center.Lymphoma diagnosis.Lymphoma Action.Lymphoma and HIV.Penn Medicine Abramson Cancer Center.Lymphoma diagnosis.American Cancer Society.Treating Hodgkin lymphoma.American Cancer Society.Immunotherapy for Hodgkin lymphoma.American Cancer Society.Chemotherapy for non-Hodgkin lymphoma.American Cancer Society.Targeted drug therapy for non-Hodgkin lymphoma.American Cancer Society.Immunotherapy for non-Hodgkin lymphoma.American Cancer Society.Surgery for non-Hodgkin lymphoma.American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.American Cancer Society.Survival rates for Hodgkin lymphoma.
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Blood Cancer UK.Lymphoma.National Cancer Institute.Hodgkin lymphoma treatment (PDQ®) - health professional version.National Cancer Institute.Reed-Sternberg cell.Penn Medicine Abramson Cancer Center.Hodgkin lymphoma.National Cancer Institute.Nodular lymphocyte-predominant Hodgkin lymphoma.Penn Medicine Abramson Cancer Center.Non-Hodgkin lymphoma (non-Hodgkin’s disease).National Cancer Institute.Non-Hodgkin lymphoma treatment (PDQ®) patient version.Follicular Lymphoma Foundation.Blood tests in follicular lymphoma.Lymphoma Research Foundation.Diffuse large B-cell lymphoma.Blood Cancer UK.Lymphoma symptoms and signs.Penn Medicine Cancer Center.Lymphoma diagnosis.Lymphoma Action.Lymphoma and HIV.Penn Medicine Abramson Cancer Center.Lymphoma diagnosis.American Cancer Society.Treating Hodgkin lymphoma.American Cancer Society.Immunotherapy for Hodgkin lymphoma.American Cancer Society.Chemotherapy for non-Hodgkin lymphoma.American Cancer Society.Targeted drug therapy for non-Hodgkin lymphoma.American Cancer Society.Immunotherapy for non-Hodgkin lymphoma.American Cancer Society.Surgery for non-Hodgkin lymphoma.American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.American Cancer Society.Survival rates for Hodgkin lymphoma.
Blood Cancer UK.Lymphoma.
National Cancer Institute.Hodgkin lymphoma treatment (PDQ®) - health professional version.
National Cancer Institute.Reed-Sternberg cell.
Penn Medicine Abramson Cancer Center.Hodgkin lymphoma.
National Cancer Institute.Nodular lymphocyte-predominant Hodgkin lymphoma.
Penn Medicine Abramson Cancer Center.Non-Hodgkin lymphoma (non-Hodgkin’s disease).
National Cancer Institute.Non-Hodgkin lymphoma treatment (PDQ®) patient version.
Follicular Lymphoma Foundation.Blood tests in follicular lymphoma.
Lymphoma Research Foundation.Diffuse large B-cell lymphoma.
Blood Cancer UK.Lymphoma symptoms and signs.
Penn Medicine Cancer Center.Lymphoma diagnosis.
Lymphoma Action.Lymphoma and HIV.
Penn Medicine Abramson Cancer Center.Lymphoma diagnosis.
American Cancer Society.Treating Hodgkin lymphoma.
American Cancer Society.Immunotherapy for Hodgkin lymphoma.
American Cancer Society.Chemotherapy for non-Hodgkin lymphoma.
American Cancer Society.Targeted drug therapy for non-Hodgkin lymphoma.
American Cancer Society.Immunotherapy for non-Hodgkin lymphoma.
American Cancer Society.Surgery for non-Hodgkin lymphoma.
American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.
American Cancer Society.Survival rates for Hodgkin lymphoma.
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
